Australia markets open in 3 hours 37 minutes

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
90.88-2.47 (-2.65%)
At close: 04:00PM EDT
90.95 +0.07 (+0.08%)
After hours: 04:22PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in EUR. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
2,729,600
3,819,000
17,310,600
18,976,700
482,300
Cost of revenue
562,900
599,800
2,995,000
2,911,500
59,300
Gross profit
2,166,700
3,219,200
14,315,600
16,065,200
423,000
Operating expenses
Research development
1,956,600
1,783,100
1,537,000
949,200
645,000
Selling general and administrative
566,300
557,700
541,200
327,200
108,500
Total operating expenses
2,424,100
2,315,000
2,011,800
1,138,100
505,400
Operating income or loss
-257,400
904,200
12,303,800
14,927,100
-82,400
Interest expense
-
-
16,200
5,400
2,000
Total other income/expenses net
-
-67,800
620,700
145,100
-59,900
Income before tax
146,600
1,186,100
12,954,100
15,046,400
-145,800
Income tax expense
33,600
255,800
3,519,700
4,753,900
-161,000
Income from continuing operations
113,000
930,300
9,434,400
10,292,500
15,200
Net income
113,000
930,300
9,434,400
10,292,500
15,200
Net income available to common shareholders
113,000
930,300
9,434,400
10,292,500
15,200
Basic EPS
11.27
3.87
38.78
42.18
0.06
Diluted EPS
11.27
3.83
37.77
39.63
0.06
Basic average shares
241,956
240,600
243,300
244,000
253,300
Diluted average shares
241,956
242,700
249,800
259,700
253,300